PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL ...

Picsart, the AI content creation platform where 100M+ creators worldwide make and monetise video content, today announced ...

Two new studies found 80-90% improvement in health outcomes and $9,000 per patient savings on average for Health ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced topline results from its Phase 2 study evaluating ...

Christopher Sprout, DDS contributes to two programs with a combined track record of restoring smiles for more than ...

Samsung TV Plus reached a milestone at the start of this year, hitting 100 million monthly active users around the world. One ...

Artificial intelligence may be the biggest technology race in the world, but SandboxAQ CEO Jack Hidary believes the United ...

On June 26, 2026, the Nuclear Regulatory Commission (NRC) published a proposed rulemaking, Modernizing Security Requirements, that includes ...

Less than a week after Wesley Family Services said it would end two of its programs for senior citizens, the nonprofit ...

Star Trek Spirits Is Back With Mission Two of Its Ultra-Premium Captain's Table Whiskey Series — and This Time Nashville's ...

Bausch + Lomb has abandoned its next great hope in glaucoma after the eye drops flunked a phase 2 study. The eye health company had been evaluating the alpha-2B agonist, dubbed BL1107, in a mid-stage ...

The Missouri Bootheel consistently ranks in the bottom of most health measures in the state, and it struggles to attract and ...